Wide variations exist in skin cancer diagnosis rates between states and metropolitan areas
Chicago, IL – Prevalence of melanoma diagnoses increased 7 percent over a four-year span, according to information released by the Blue Cross Blue Shield Association (BCBSA)’s Health of America Report.
According to the Skin Cancer Foundation, people who first use a tanning bed before age 35 increase their risk for melanoma by 75 percent. “Skin exposure to ultraviolet light is as likely to cause cancer as smoking cigarettes,” said Dr. Trent Haywood, senior vice president and chief medical officer for BCBSA. “Americans should enjoy the sun, but also use the proper precautions to avoid too much exposure to ultraviolet light. Tanning beds should be avoided altogether in light of research documenting the strong correlation to skin cancer.”
Findings show that the rate of Blue Cross and Blue Shield (BCBS) members living with melanoma more than double when men reach ages 55 through 64 and surpass rates for women in that age range. Women 54 years and younger have higher prevalence of diagnosed melanoma than men. Non-melanoma skin cancer diagnoses are more prevalent in women at 4.6 percent compared to men at 3.5 percent, but the average cost of treating women is $468 compared to $678 for men.
In 2013, 237,000 commercially insured BCBS members within a sample of 41 million people were identified as having diagnosed melanoma, compared to 257,000 in 2016. Despite the increase, melanoma made up just 2.8 percent of all skin cancer diagnoses.
Skin cancer is the most common cancer in the United States: Nearly 9,500 people in the U.S. are diagnosed with it every single day, according to the American Academy of Dermatology. Skin cancer affected 4.3 percent of BCBS members. By taking the skin cancer diagnosis rate found in the study and extrapolating it to 216 million privately insured people counted by the U.S. Census Bureau, BCBSA estimates that nine million privately insured people in the U.S. are living with a skin cancer diagnosis.
BCBSA also published a list ranking states and metropolitan areas by skin cancer prevalence (including basal cell carcinoma, squamous cell carcinoma, melanoma and other uncommon skin cancers) and found:
States with the highest diagnosed skin cancer prevalence rates include:
- Florida (7.1 percent)
- Washington, D.C. (5.8 percent)
- Connecticut (5.6 percent)
- Maryland (5.3 percent)
- Rhode Island (5.3 percent)
- Vermont (5.3 percent)
States with the lowest rates include:
- Hawaii (1.8 percent)
- Oklahoma (2.6 percent)
- Mississippi (2.7 percent)
- North Dakota (2.8 percent)
- Wisconsin (2.9 percent)
Cities with the highest rates:
- Sarasota-Bradenton, FL (10.0 percent)
- Fort Pierce-Port St. Lucie, FL (9.5 percent)
- West Palm Beach-Boca Raton, FL (9.5 percent)
- Barnstable-Yarmouth, MA ( 8.6 percent)
- Melbourne-Titusville-Palm Bay, FL (8.6 percent)
Cities with the lowest rates:
- Laredo, TX (1.1 percent)
- Brownsville-Harlingen-San Benito, TX (1.4 percent)
- El Paso, TX (1.4 percent)
- Mcallen-Edinburg-Mission, TX (1.4 percent)
- Honolulu, HI (1.5 percent)
The findings are based on medical claims data from the Blue Cross Blue Shield Health IndexSM (BCBS Health Index℠), a first-of-its-kind measurement of health for nearly every county in America. It encompasses more than 200 conditions that impact health and identifies those health conditions with the greatest impact on the commercially insured population. The BCBS Health Index is powered by de-identified medical claims data from more than 41 million commercially insured members of BCBS companies. The interactive website allows people to measure the overall health and identify the top 10 conditions that negatively impact health at the state and county levels.
The Blue Cross Blue Shield: The Health of America Report® is a collaboration between BCBSA and Blue Health Intelligence, which uses a market-leading claims database to uncover key trends and insights into health care affordability and access to care.
For more information, visit https://www.bluehealthintelligence.com/index.php
About Blue Health Intelligence®
Leveraging the power of medical and pharmacy claims data from more than 180 million Americans, Blue Health Intelligence (BHI) delivers insights that empower healthcare organizations to improve patient care, reduce costs, and optimize performance. With the largest, most up-to-date, and uniform data set in healthcare, BHI provides an accurate representation of the health profile of commercially insured Americans. Our team of data analysts, clinicians, IT experts, and epidemiologists provide analytics, software as a service, and in-depth consulting to payors, providers, employers, medical device companies, and other healthcare stakeholders. Blue Health Intelligence is an independent licensee of the Blue Cross Blue Shield Association and carries the trade name of Health Intelligence Company, LLC. For more information, visit www.bluehealthintelligence.com.
ABOUT BLUE CROSS BLUE SHIELD ASSOCIATION
The Blue Cross and Blue Shield Association is a national federation of 36 independent, community-based and locally operated Blue Cross and Blue Shield companies that collectively provide health care coverage for one in three Americans. BCBSA provides health care insights through The Health of America Report series and the national BCBS Health Indexsm. For more information on BCBSA and its member companies, please visit BCBS.com. We also encourage you to connect with us on Facebook , check out our videos on YouTube , follow us on Twitter and check out our blog.